AKT1 and cancer: The results showed that the downstream targets by the TFs were significantly enriched in a few critical cancer-related pathways, such as PI3K-Akt signaling pathway, cell cycle, FoxO signaling pathway, small cell lung cancer, p53 signaling pathway (Fig. 7F, Supplementary excel 5).